Case report: Sustained complete remission with all-oral MEPED therapy in a patient with Hodgkin's disease developing resistance to pembrolizumab

Case report: Sustained complete remission with all-oral MEPED therapy in a patient with Hodgkin's disease developing resistance to pembrolizumab

Targeted chemotherapy and immune checkpoint inhibitors (ICPi) have expanded the spectrum of therapies for patients with relapsed/refractory (r/r) Hodgkin's disease and significantly improved the proportion of patients with long-term disease control. However, there is no standardized therapeutic...

Full description

Saved in:
Bibliographic Details
Main Authors: K. Reuthner (Author), P. Aubele (Author), K. Menhart (Author), P. Rath (Author), D. C. Harrer (Author), W. Herr (Author), J. Hahn (Author), M. Vogelhuber (Author), D. Heudobler (Author), F. Lueke (Author), A. Reichle (Author), M. Grube (Author)
Format: Book
Published: Frontiers Media S.A., 2024-02-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items